Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission
Xiaoxuan Lai
1, 2
,
Jinyan Xiao
1, 2
,
Tanzhen Wang
1, 2
,
Chang Hou
1, 2
,
Jia Chen
1, 2
,
Depei Wu
1, 2
,
Yang Xu
1, 2
Publication type: Journal Article
Publication date: 2023-11-22
scimago Q2
wos Q3
SJR: 0.778
CiteScore: 4.1
Impact factor: 2.2
ISSN: 10428194, 10292403, 10268022
PubMed ID:
37990829
Cancer Research
Oncology
Hematology
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
British Journal of Haematology
1 publication, 50%
|
|
|
Annals of Hematology
1 publication, 50%
|
|
|
1
|
Publishers
|
1
|
|
|
Wiley
1 publication, 50%
|
|
|
Springer Nature
1 publication, 50%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Total citations:
2
Citations from 2024:
2
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Lai X. et al. Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission // Leukemia and Lymphoma. 2023. Vol. 65. No. 3. pp. 363-371.
GOST all authors (up to 50)
Copy
Lai X., Xiao J., Wang T., Hou C., Chen J., Wu D., Xu Y. Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission // Leukemia and Lymphoma. 2023. Vol. 65. No. 3. pp. 363-371.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/10428194.2023.2284089
UR - https://doi.org/10.1080/10428194.2023.2284089
TI - Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission
T2 - Leukemia and Lymphoma
AU - Lai, Xiaoxuan
AU - Xiao, Jinyan
AU - Wang, Tanzhen
AU - Hou, Chang
AU - Chen, Jia
AU - Wu, Depei
AU - Xu, Yang
PY - 2023
DA - 2023/11/22
PB - Taylor & Francis
SP - 363-371
IS - 3
VL - 65
PMID - 37990829
SN - 1042-8194
SN - 1029-2403
SN - 1026-8022
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Lai,
author = {Xiaoxuan Lai and Jinyan Xiao and Tanzhen Wang and Chang Hou and Jia Chen and Depei Wu and Yang Xu},
title = {Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission},
journal = {Leukemia and Lymphoma},
year = {2023},
volume = {65},
publisher = {Taylor & Francis},
month = {nov},
url = {https://doi.org/10.1080/10428194.2023.2284089},
number = {3},
pages = {363--371},
doi = {10.1080/10428194.2023.2284089}
}
Cite this
MLA
Copy
Lai, Xiaoxuan, et al. “Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission.” Leukemia and Lymphoma, vol. 65, no. 3, Nov. 2023, pp. 363-371. https://doi.org/10.1080/10428194.2023.2284089.